|
Volumn 93, Issue 2, 2002, Pages 190-197
|
Therapeutic and analysis model of intrahepatic metastasis reflects clinical behavior of hepatocellular carcinoma
|
Author keywords
Hepatocellular carcinoma; Intrahepatic metastasis; Metastasis model; MMP inhibitor; Orthotopic implantation
|
Indexed keywords
CISPLATIN;
DOXORUBICIN;
GELATINASE B;
MATRIX METALLOPROTEINASE INHIBITOR;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CANCER INHIBITION;
CANCER TRANSPLANTATION;
CLINICAL FEATURE;
CONTROLLED STUDY;
DISEASE COURSE;
DISEASE MODEL;
ENZYME ACTIVITY;
ENZYME RELEASE;
FEMALE;
GROWTH INHIBITION;
LIVER CELL CARCINOMA;
LIVER METASTASIS;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
TIME;
TUMOR VOLUME;
WEIGHT REDUCTION;
ANIMALS;
CARCINOMA, HEPATOCELLULAR;
CISPLATIN;
DISEASE MODELS, ANIMAL;
DOXORUBICIN;
FEMALE;
LIVER NEOPLASMS;
MATRIX METALLOPROTEINASE 9;
MICE;
NEOPLASM TRANSPLANTATION;
PHENYL ETHERS;
|
EID: 0036122304
PISSN: 09105050
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1349-7006.2002.tb01258.x Document Type: Article |
Times cited : (17)
|
References (35)
|